- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 625892, 13 pages
Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter Gourd
Department of Biochemical Science and Technology, National Taiwan University, Taipei 106, Taiwan
Received 29 November 2012; Revised 26 January 2013; Accepted 7 February 2013
Academic Editor: I-Min Liu
Copyright © 2013 Ting-ni Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- W. Kim and J. M. Egan, “The role of incretins in glucose homeostasis and diabetes treatment,” Pharmacological Reviews, vol. 60, no. 4, pp. 470–512, 2008.
- L. L. Baggio and D. J. Drucker, “Biology of incretins: GLP-1 and GIP,” Gastroenterology, vol. 132, no. 6, pp. 2131–2157, 2007.
- J. J. Holst, “The physiology of glucagon-like peptide 1,” Physiological Reviews, vol. 87, no. 4, pp. 1409–1439, 2007.
- P. L. Brubaker, “Minireview: update on incretin biology: focus on glucagon-like peptide-1,” Endocrinology, vol. 151, no. 5, pp. 1984–1989, 2010.
- F. Reimann, G. Tolhurst, and F. M. Gribble, “G-protein-coupled receptors in intestinal chemosensation,” Cell Metabolism, vol. 15, no. 4, pp. 421–431, 2012.
- K. Iwatsuki and K. Torii, “Peripheral chemosensing system for tastants and nutrients,” Current Opinion in Endocrinology, Diabetes, and Obesity, vol. 19, no. 1, pp. 19–25, 2012.
- S. Edfalk, P. Steneberg, and H. Edlund, “Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion,” Diabetes, vol. 57, no. 9, pp. 2280–2287, 2008.
- A. Hirasawa, K. Tsumaya, T. Awaji et al., “Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120,” Nature Medicine, vol. 11, no. 1, pp. 90–94, 2005.
- L. M. Lauffer, R. Iakoubov, and P. L. Brubaker, “GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell,” Diabetes, vol. 58, no. 5, pp. 1058–1066, 2009.
- C. Thomas, A. Gioiello, L. Noriega et al., “TGR5-mediated bile acid sensing controls glucose homeostasis,” Cell Metabolism, vol. 10, no. 3, pp. 167–177, 2009.
- S. Moran-Ramos, A. R. Tovar, and N. Torres, “Diet: friend or foe of enteroendocrine cells–how it interacts with enteroendocrine cells.,” Advances in Nutrition, vol. 3, no. 1, pp. 8–20, 2012.
- C. D. Dotson, S. Vigues, N. I. Steinle, and S. D. Munger, “T1R and T2R receptors: the modulation of incretin hormones and potential targets for the treatment of type 2 diabetes mellitus,” Current Opinion in Investigational Drugs, vol. 11, no. 4, pp. 447–454, 2010.
- M. . Behrens and W. Meyerhof, “Gustatory and extragustatory functions of mammalian taste receptors,” Physiology & Behavior, vol. 105, no. 1, pp. 4–13, 2011.
- H. J. Jang, Z. Kokrashvili, M. J. Theodorakis et al., “Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 38, pp. 15069–15074, 2007.
- A. G. Renwick and S. V. Molinary, “Sweet-taste receptors, low-energy sweeteners, glucose absorption and insulin release,” British Journal of Nutrition, vol. 104, no. 10, pp. 1415–1420, 2010.
- A. C. Gerspach, R. E. Steinert, L. Schönenberger, A. Graber-Maier, and C. Beglinger, “The role of the gut sweet taste receptor in regulating glp-1, PYY, and CCK release in humans,” American Journal of Physiology, vol. 301, no. 2, pp. E317–E325, 2011.
- H. E. Ford, V. Peters, N. M. Martin et al., “Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects,” European Journal of Clinical Nutrition, vol. 65, no. 4, pp. 508–513, 2011.
- S. V. Wu, N. Rozengurt, M. Yang, S. H. Young, J. Sinnett-Smith, and E. Rozengurt, “Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 2392–2397, 2002.
- N. Rozengurt, S. V. Wu, M. C. Chen, C. Huang, C. Sternini, and E. Rozengurt, “Colocalization of the α-subunit of gustducin with PYY and GLP-1 in L cells of human colon,” American Journal of Physiology, vol. 291, no. 5, pp. G792–G802, 2006.
- T. I. Jeon, B. Zhu, J. L. Larson, and T. F. Osborne, “SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice,” Journal of Clinical Investigation, vol. 118, no. 11, pp. 3693–3700, 2008.
- C. D. Dotson, L. Zhang, H. Xu et al., “Bitter taste receptors influence glucose homeostasis,” PLoS ONE, vol. 3, no. 12, Article ID e3974, 2008.
- J. K. Grover and S. P. Yadav, “Pharmacological actions and potential uses of Momordica charantia: a review,” Journal of Ethnopharmacology, vol. 93, no. 1, pp. 123–132, 2004.
- M. B. Krawinkel and G. B. Keding, “Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia,” Nutrition Reviews, vol. 64, no. 7, pp. 331–337, 2006.
- E. Basch, S. Gabardi, and C. Ulbricht, “Bitter melon (Momordica charantia): a review of efficacy and safety,” American Journal of Health-System Pharmacy, vol. 60, no. 4, pp. 356–359, 2003.
- P. Chaturvedi, “Antidiabetic potentials of Momordica charantia: multiple mechanisms behind the effects,” Journal of Medicinal Food, vol. 15, no. 2, pp. 101–107, 2012.
- J. Singh, E. Cumming, G. Manoharan, H. Kalasz, and E. Adeghate, “Medicinal chemistry of the anti-diabetic effects of Momordica charantia: active constituents and modes of actions,” The Open Medicinal Chemistry Journal, vol. 5, supplement 2, pp. 70–77, 2011.
- T. Uebanso, H. Arai, Y. Taketani et al., “Extracts of Momordica charantia suppress postprandial hyperglycemia in rats,” Journal of Nutritional Science and Vitaminology, vol. 53, no. 6, pp. 482–488, 2007.
- M. F. Mahomoodally, A. Gurib-Fakim, and A. H. Subratty, “Effect of exogenous ATP on Momordica charantia Linn. (Cucurbitaceae) induced inhibition of d-glucose, l-tyrosine and fluid transport across rat everted intestinal sacs in vitro,” Journal of Ethnopharmacology, vol. 110, no. 2, pp. 257–263, 2007.
- I. Ahmed, E. Adeghate, A. K. Sharma, D. J. Pallot, and J. Singh, “Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat,” Diabetes Research and Clinical Practice, vol. 40, no. 3, pp. 145–151, 1998.
- A. C. Keller, J. Ma, A. Kavalier, et al., “Saponins from the traditional medicinal plantMomordica charantiastimulate insulin secretion in vitro,” Phytomedicine, vol. 19, no. 1, pp. 32–37, 2011.
- N. P. C. Fernandes, C. V. Lagishetty, V. S. Panda, and S. R. Naik, “An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract,” BMC Complementary and Alternative Medicine, vol. 7, article 29, 2007.
- S. S. Rathi, J. K. Grover, and V. Vats, “The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism,” Phytotherapy Research, vol. 16, no. 3, pp. 236–243, 2002.
- S. Sarkar, M. Pranava, and R. A. Marita, “Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes,” Pharmacological Research, vol. 33, no. 1, pp. 1–4, 1996.
- M. J. Tan, J. M. Ye, N. Turner et al., “Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway,” Chemistry and Biology, vol. 15, no. 3, pp. 263–273, 2008.
- H. L. Cheng, H. K. Huang, C. I. Chang, C. P. Tsai, and C. H. Chou, “A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase,” Journal of Agricultural and Food Chemistry, vol. 56, no. 16, pp. 6835–6843, 2008.
- C. C. Shih, C. H. Lin, W. L. Lin, and J. B. Wu, “Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats,” Journal of Ethnopharmacology, vol. 123, no. 1, pp. 82–90, 2009.
- Z. Q. Wang, X. H. Zhang, and Y. Yu, “Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice,” The Journal of Nutritional Biochemistry, vol. 22, no. 11, pp. 1064–1073, 2011.
- C. Y. Chao and C. J. Huang, “Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells,” Journal of Biomedical Science, vol. 10, no. 6, pp. 782–791, 2003.
- C. Y. Chuang, C. Hsu, C. Y. Chao, Y. S. Wein, Y. H. Kuo, and C. J. Huang, “Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARα in bitter gourd (Momordica charantia L.),” Journal of Biomedical Science, vol. 13, no. 6, pp. 763–772, 2006.
- C. H. Tsai, E. C. Chen, H. S. Tsay, and C. J. Huang, “Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial,” Nutrition Journal, vol. 11, p. 4, 2012.
- C. Hsu, C. L. Hsieh, Y. H. Kuo, and C. J. Huang, “Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia,” Journal of Agricultural and Food Chemistry, vol. 59, no. 9, pp. 4553–4561, 2011.
- P. Khanna, S. C. Jain, A. Panagariya, and V. P. Dixit, “Hypoglycemic activity of polypeptide-p from a plant source,” Journal of Natural Products, vol. 44, no. 6, pp. 648–655, 1981.
- H. Okabe, Y. Miyahara, and T. Yamauchi, “Studies on the constituents of Momordica charantia L. IV. Characterization of the new cucurbitacin glycosides of the immature fruits. (2) Structures of the bitter glycosides, momordicosides K and L,” Chemical and Pharmaceutical Bulletin, vol. 30, no. 12, pp. 4334–4340, 1982.
- J. I. Eiki, K. Saeki, N. Nagano et al., “A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarization-coupled Ca2+ influx,” Journal of Endocrinology, vol. 201, no. 3, pp. 361–367, 2009.
- T. A. Greene, S. Alarcon, A. Thomas et al., “Probenecid inhibits the human bitter taste receptor TAS2R16 and suppresses bitter perception of salicin,” PLoS ONE, vol. 6, no. 5, Article ID e20123, 2011.
- S. C. Hsu and C. J. Huang, “Reduced fat mass in rats fed a high oleic acid-rich safflower oil diet is associated with changes in expression of hepatic PPARα and adipose SREBP-1c-regulated genes,” Journal of Nutrition, vol. 136, no. 7, pp. 1779–1785, 2006.
- P. G. Reeves, F. H. Nielsen, and G. C. Fahey, “AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet,” Journal of Nutrition, vol. 123, no. 11, pp. 1939–1951, 1993.
- B. Bufel, T. Hofmann, D. Krautwurst, J. D. Raguse, and W. Meyerhof, “The human TAS2R16 receptor mediates bitter taste in response to β-glucopyranosides,” Nature Genetics, vol. 32, no. 3, pp. 397–401, 2002.
- I. Masuho, M. Tateyama, and O. Saitoh, “Characterization of bitter taste responses of intestinal STC-1 cells,” Chemical Senses, vol. 30, no. 4, pp. 281–290, 2005.
- M. C. P. Geraedts, F. J. Troost, M. A. J. G. Fischer, L. Edens, and W. H. M. Saris, “Direct induction of CCK and GLP-1 release from murine endocrine cells by intact dietary proteins,” Molecular Nutrition and Food Research, vol. 55, no. 3, pp. 476–484, 2011.
- Q. Chen, L. L. Y. Chan, and E. T. S. Li, “Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet,” Journal of Nutrition, vol. 133, no. 4, pp. 1088–1093, 2003.
- G. Tolhurst, F. Reimann, and F. M. Gribble, “Nutritional regulation of glucagon-like peptide-1 secretion,” Journal of Physiology, vol. 587, no. 1, pp. 27–32, 2009.
- K. Hostettmann and A. Marston, Saponins, Cambridge University Press, Cambrige, UK, 1995.
- L. Harinantenaina, M. Tanaka, S. Takaoka et al., “Momordica charantia constituents and antidiabetic screening of the isolated major compounds,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 7, pp. 1017–1021, 2006.
- K. Iwatsuki and H. Uneyama, “Sense of taste in the gastrointestinal tract,” Journal of Pharmacological Sciences, vol. 118, no. 2, pp. 123–128, 2012.
- W. Meyerhof, C. Batram, C. Kuhn et al., “The molecular receptive ranges of human TAS2R bitter taste receptors,” Chemical Senses, vol. 35, no. 2, pp. 157–170, 2009.